Bone Growth Stimulator Market By Product (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins, Platelet-rich Plasma), Application (Spinal Fusion Surgeries, Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries), End-User (Hospitals and Ambulatory Surgical Centers, Home Care Settings, Academic and Research Institutes), & Region for 2024-2031

Bone Growth Stimulator Market Valuation – 2024-2031

The rising incidence of osteoporosis globally is driving the demand for bone growth stimulators. Thus, the increasing prevalence of osteoporosis and related fractures surged the growth of market size surpassing USD 1.18 Billion in 2023 to reach a valuation of USD 1.87 Billion in 2023 to reach a valuation of USD 3.33 Billion by 2031.

The expanding elderly population is more susceptible to bone disorders and fractures, increasing the need for bone growth stimulators. Thus, the growing aging population enables the market to grow at a CAGR of 7.5% from 2024 to 2031.

>> Get | Download Sample Report @ – https://www.verifiedmarketresearch.com/download-sample/?rid=23909

To Get Detailed Analysis: Download Report PDF

Bone Growth Stimulator Market: Definition/ Overview

A bone growth stimulator is a specialized medical device designed to aid in the healing and regeneration of bone tissue. It operates by emitting low-level electromagnetic fields or acoustic waves that stimulate bone cells, promoting their activity to facilitate growth and repair. This innovative technology is primarily utilized in orthopedic medicine, particularly in cases of fractures that are slow to heal or classified as non-union fractures, where the natural bone healing process fails. By enhancing cellular activity, bone growth stimulators play a crucial role in accelerating recovery and ensuring proper bone formation.

In addition to fracture treatment, these devices are commonly used in spinal fusion surgeries, where they help to fuse vertebrae more effectively by encouraging bone regeneration. They are also gaining traction in treating conditions like osteoporosis and osteoarthritis, where they contribute to strengthening bone density and alleviating pain by promoting healthier bone tissue.

Bone growth stimulators have become an essential tool for improving patient outcomes, especially in cases where conventional healing is delayed or impaired. By expediting the healing process, reducing recovery times, and enhancing the overall success of treatments, these devices significantly benefit individuals suffering from bone-related injuries or diseases, providing a non-invasive solution to complex orthopedic challenges.

What's inside a VMR
industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

>>> Ask For Discount @ – https://www.verifiedmarketresearch.com/ask-for-discount/?rid=23909

How the Rising Incidence of Sports-Related Injuries Surge the Growth of Bone Growth Stimulator Market?

Increasing participation in sports activities has led to a higher number of sports-related injuries, boosting the demand for bone growth stimulators. The National Safety Council reported that in 2020, approximately 3.2 million people were treated in emergency departments for injuries related to sports and recreational activities in the United States alone. Ongoing innovations in bone growth stimulator technology are driving market growth. A report by the National Center for Biotechnology Information in 2022 stated that the global bone growth stimulators market was valued at USD 1.41 Billion in 2020 and is projected to reach USD 1.86 Billion by 2025, growing at a CAGR of 5.6%.

The shift towards minimally invasive surgeries is boosting the use of bone growth stimulators in post-operative care. According to a 2021 study published in the Journal of Orthopaedic Surgery and Research, the use of bone growth stimulators in minimally invasive spinal fusion surgeries increased by 18% between 2018 and 2020. Increased healthcare spending globally is facilitating greater access to advanced medical technologies, including bone growth stimulators. The World Health Organization reported that global health spending reached $8.5 trillion in 2019, with projections indicating a further increase to USD 10 Trillion by 2022, representing about 10% of global GDP. According to the International Osteoporosis Foundation, as of 2021, osteoporosis causes more than 8.9 million fractures annually worldwide, with 1 in 3 women and 1 in 5 men over 50 experiencing an osteoporotic fracture in their lifetime.

How Does the High Cost of Bone Growth Stimulator Devices Impede the Growth of Bone Growth Stimulator Market?

The expensive nature of these devices can limit their adoption, especially in developing countries. According to a 2021 study published in the Journal of Orthopaedic Surgery and Research, the average cost of a bone growth stimulator device ranges from $2,000 to $5,000, which can be prohibitively expensive for many patients without insurance coverage. Inconsistent or inadequate reimbursement policies for bone growth stimulator devices can hinder market growth. A 2022 report by the Centers for Medicare & Medicaid Services (CMS) indicated that Medicare only covers bone growth stimulators for specific conditions, such as nonunion fractures, failed spinal fusion, and congenital pseudarthrosis, limiting broader adoption.

The shortage of healthcare professionals trained in the proper use and application of bone growth stimulators can restrain market growth. The Association of American Medical Colleges (AAMC) projected in 2021 that the United States could face a shortage of up to 124,000 physicians by 2034, including specialists needed for complex orthopedic treatments. Strict regulatory requirements for bone growth stimulator devices can slow down product launches and market expansion. The U.S. Food and Drug Administration (FDA) reported in 2022 that the average time for 510(k) clearance for orthopedic devices, including bone growth stimulators, was approximately 177 days, potentially delaying market entry for new products.

Category-Wise Acumens

How Does the Increasing Demand for Growth Stimulation Devices Foster the Growth of Spinal Fusion Surgeries Segment?

The spinal fusion surgeries segment dominates the bone growth stimulator market, owing to the widespread use of bone growth stimulation devices in these procedures. Spinal fusion involves permanently joining two or more vertebrae to stabilize the spine, and bone growth stimulators are essential in accelerating the healing process by promoting proper bone fusion. These devices generate low-level electromagnetic fields or acoustic waves, stimulating bone cells (osteoblasts) to enhance growth and repair, making them highly effective in spinal fusion surgeries.

The increasing prevalence of degenerative spine conditions, such as degenerative disc disease and spinal deformities, alongside the rising number of sports injuries, has driven the demand for bone growth stimulation devices in spinal surgeries. Non-union fractures and slow healing are common challenges in these procedures, making bone growth stimulators crucial for ensuring successful vertebral fusion and reducing recovery times. Additionally, the aging population and the growing number of spinal surgeries contribute to the segment’s dominance.

How does the Increasing Demand for Non-invasive Technologies Surge the Growth of the Bone Growth Stimulation Devices Segment?

The bone growth stimulation devices segment holds a dominant position in the bone growth stimulator market, owing to the increasing demand for non-invasive technologies. These devices, including ultrasound bone growth stimulators and electromagnetic field-based stimulators, are designed to enhance the body’s natural healing process by stimulating bone cell activity. They are particularly effective in treating fractures that are slow to heal or non-union fractures.

The rising prevalence of orthopedic conditions and sports injuries necessitates advanced treatments to ensure optimal recovery. Additionally, bone growth stimulators are increasingly used in spinal fusion surgeries, where they promote faster and more effective fusion between vertebrae, reducing recovery time and complications.

The growing focus on developing novel, non-invasive bone growth stimulators has further fueled the demand for these products. Patients and healthcare providers are increasingly seeking out these advanced devices for their ability to deliver effective results without surgical intervention. As orthopedic conditions, sports injuries, and spinal fusion surgeries become more common, the bone growth stimulation devices segment is expected to continue dominating the bone growth stimulator market.

Gain Access to Bone Growth Stimulator Market Report Methodology

https://www.verifiedmarketresearch.com/select-licence/?rid=23909

Country/Region-wise Acumens

How the Aging Population and Rising Prevalence of Orthopedic Conditions & Sports Injuries Escalate the Growth of the Bone Growth Stimulation Market in Asia Pacific?

Asia Pacific substantially dominates the bone growth stimulation market driven by the increasing population and increasing prevalence of orthopedic conditions and sports injuries. Japan has the world’s highest elderly population ratio, with 29.1% of its population aged 65+ as of September 2021. South Korea’s elderly population (65+) reached 16.5% in 2021 and is projected to reach 20% by 2025 (Korean Statistical Information Service) China’s 60+ population exceeded 267 million in 2021, accounting for 18.9% of the total population (National Bureau of Statistics China)

In China, osteoporosis affects approximately 19.2% of people aged 50+ years, representing about 94.6 million people (Chinese National Health Commission, 2021) In India, sports injuries increased by 32% between 2020-2022, with 58% involving bone and joint trauma. Japan reported over 13 million cases of osteoporosis in 2022, with an annual treatment cost of approximately ¥250 billion (Japan Osteoporosis Society)

Healthcare spending in Southeast Asia grew by 11.5% CAGR between 2020-2022 (World Health Organization SEARO). China’s healthcare expenditure reached 7.2 trillion yuan in 2022, representing 6.6% of GDP. India increased its healthcare budget by 137% in 2021-22 compared to 2020-21.

How the Advanced Healthcare Infrastructure & High Healthcare Spending Foster the Growth of Bone Growth Stimulation Market in North America?

North America is anticipated to witness the fastest growth in the bone growth stimulation market during the forecast period owing to the robust healthcare infrastructure and increasing investment in healthcare. of U.S. healthcare spending reached USD 4.3 Trillion in 2021, accounting for 18.3% of GDP. The U.S. performed over 1.62 million minimally invasive orthopedic procedures in 2022 (American Academy of Orthopedic Surgeons)

Medicare spending on orthopedic devices and procedures increased by 23% between 2020-2022. Medicare coverage for bone growth stimulators expanded in 2021, covering 80% of approved devices. Private insurance coverage for orthopedic devices increased by 15% from 2020 to 2022. Average reimbursement rates for bone growth stimulation procedures increased by 12% between 2021-2023.

Approximately 54 million U.S. adults have been diagnosed with arthritis. According to the National Safety Council Report sports-related injuries in the U.S. resulted in 3.2 million emergency department visits in 2022. About 10 million Americans have osteoporosis, and another 44 million have low bone density.

Competitive Landscape

The competitive landscape of the Bone Growth Stimulator market is dynamic and evolving, with new players and technologies emerging regularly. Companies must continuously adapt to the changing market conditions to remain competitive and meet the needs of patients and healthcare providers.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the bone growth stimulator market include:

• Zimmer Biomet
• Stryker Corporation
• Johnson & Johnson
• Ossur hf.
• Braun Melsungen AG
• DJO Global
• Arthrogenix
• IEX Medical
• EMS Physiotherapy Equipment Ltd.
• SONOSTAT
• Alvar

Latest Developments:

• In February 2024, Mainstay Medical announced a US$125 million equity fundraising transaction. This news demonstrates a significant investment in the bone growth stimulator field, which may imply future market expansion and development.
• In February 2024, Orthofix got FDA and CE Mark approval for new bone growth stimulants. This article focuses on regulatory approvals for new bone growth stimulators, as well as future technological and therapeutic improvements.
• In February 2024, SI-BONE, Inc., a firm that specializes in sacroiliac joint fusion using minimally invasive methods, released financial results.

Report Scope

Bone Growth Stimulator Market, By Category

Product:

• Bone Growth Stimulation Devices
• Bone Morphogenetic Proteins
• Platelet-rich Plasma

Application:

• Spinal Fusion Surgeries
• Delayed Union & Nonunion Bone Fractures
• Oral & Maxillofacial Surgeries

End-User:

• Hospitals and Ambulatory Surgical Centers
• Home Care Settings
• Academic and Research Institutes

Region:

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Research Methodology of Verified Market Research:

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

• In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.